HALO
Halozyme Therapeutics, Inc. · Healthcare
Director Connie Matsui sold $1.3M of Halozyme Therapeutics, Inc.
Sold$1,292,113
$40.38Price
32,000Shares
−15%Stake
What HALO did after the filing
- The stock from Fri, Nov 5 close, $40.71
- −6.2%
- S&P 500, same days
- −2.6%
Measured over 30 trading days, to the Dec 20 close.
Traded Fri, Nov 5. Filed Fri, Nov 5, 1:59 PM ET, during the session. Returns use the Nov 5 close and the Dec 20 close. Not investment advice.